Loxicom® 50 mg/g Oral Paste for Horses
A pale yellow homogenous oral paste.
One gram contains:
Active substance: Meloxicam - 50 mg
Excipient: Benzyl Alcohol - 10 mg
Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses.
Dosage & Administration
Administer 0.6 mg/kg body weight, once daily for up to 14 days.
To be administered directly into the mouth over the back of the tongue keeping the animal’s head raised until swallowed.
One syringe division of paste should be administered per 50 kg bodyweight. The syringe has an integrated adapter and has a kg/bodyweight graduation. Each syringe delivers 420 mg meloxicam, sufficient to treat 700 kg of bodyweight.
Click here to see the number of tubes required depending on treatment regime.
Meat and offal: 3 days.
Not authorised for use in animals producing milk for human consumption.
Contraindictions, Warnings etc
Do not use in pregnant or lactating mares.
Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Do not use in horses less than 6 weeks of age.
Laboratory studies in cattle have not provided any evidence for teratogenic, foetotoxic, or maternotoxic effects. However, no data have been generated in horses. Therefore the use in this species is not recommended during pregnancy and lactation.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Isolated cases of adverse reactions typically associated with NSAIDs were observed in clinical trials (slight urticaria, diarrhoea). Symptoms were reversible.
Commonly, a reduction in blood albumin concentration will occur during the period of treatment (up to 14 days).
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported. In very rare cases anaphylactoid reactions, which may be serious (including fatal), may occur and should be treated symptomatically. If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Advice On Correct Administration
Avoid introduction of contamination during use.
Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of renal toxicity.
Do not exceed the recommended dose or duration of treatment due to the possibility of severe adverse reactions.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
People with known hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
Avoid skin and eye contact with the product. If skin and/or eye contact occurs, wash the affected parts immediately with water. Should irritation occur and persist, seek medical advice.
In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Shelf life of the veterinary medicinal product as packaged for sales: 18 months.
Shelf life after first opening the immediate packaging: 28 days
Store below 30 ºC
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Click here to read the SPC.